Calamos Advisors’s Summit Therapeutics SMMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$492K Sell
23,117
-860
-4% -$18.3K ﹤0.01% 706
2025
Q1
$463K Buy
23,977
+156
+0.7% +$3.01K ﹤0.01% 689
2024
Q4
$425K Sell
23,821
-22,926
-49% -$409K ﹤0.01% 714
2024
Q3
$1.02M Buy
+46,747
New +$1.02M ﹤0.01% 637